技术领域Technical Field
本发明属于医疗辅助设备技术领域，涉及一种肿瘤科用辅助设备，具体涉及一种核素治疗后使用的自动水化治疗系统。The invention belongs to the technical field of medical auxiliary equipment, and relates to an auxiliary equipment for oncology, and in particular to an automatic hydration treatment system used after radionuclide treatment.
背景技术Background technique
部分甲状腺乳头状癌术后患者，会因病情需要而行核素131碘化钠内照射治疗。在行核素131碘化钠内照射治疗后给予此类患者水化治疗(静脉输注辅助治疗液体)至关重要。通过水化治疗，可加快患者体内放射性核素物质的排泄，缓解放射线为患者带来的辐射损伤。Some patients who have undergone surgery for papillary thyroid cancer will undergo radionuclide131 sodium iodide internal irradiation therapy due to their condition. It is crucial to give such patients hydration therapy (intravenous infusion of adjuvant treatment fluid) after radionuclide131 sodium iodide internal irradiation therapy. Through hydration therapy, the excretion of radioactive nuclides in the patient's body can be accelerated, and the radiation damage caused by radiation to the patient can be alleviated.
但是，目前为止未发现成熟的自动水化治疗仪。在临床实践中，大部分都是通过护理人员人工进行水化治疗。这样，一方面严重增加了护理人员的工作量，另一方面护理人员会受到额外的辐射损伤，再者，进行水化治疗工作人员较少，从而使得水化治疗难以及时进行，从而降低了核素治疗的效率和增加了患者的辐射损失。However, no mature automatic hydration therapy device has been found so far. In clinical practice, hydration therapy is mostly performed manually by nurses. This, on the one hand, seriously increases the workload of nurses, on the other hand, nurses will suffer additional radiation damage. Moreover, there are fewer staff members for hydration therapy, which makes it difficult to perform hydration therapy in a timely manner, thereby reducing the efficiency of radionuclide therapy and increasing the radiation loss of patients.
因此，鉴于现有技术的缺陷，迫切需要研制一种能够进行水化治疗的自动化设备。Therefore, in view of the defects of the prior art, there is an urgent need to develop an automated device capable of performing hydration therapy.
发明内容Summary of the invention
本发明的目的在于克服现有技术中存在的缺点，提供一种核素治疗后使用的自动水化治疗系统，其可降低医护人员的工作量，并减少医护人员及患者受到的辐射，提高核素治疗效率。The purpose of the present invention is to overcome the shortcomings of the prior art and provide an automatic hydration therapy system for use after radionuclide therapy, which can reduce the workload of medical staff, reduce the radiation received by medical staff and patients, and improve the efficiency of radionuclide therapy.
为了实现上述目的，本发明提供如下技术方案：In order to achieve the above object, the present invention provides the following technical solutions:
一种核素治疗后使用的自动水化治疗系统，其包括位于辐射防护病房的病床的床头的患者端和位于辐射防护病区内的自动仪，所述患者端和自动仪通过管道相连，其特征在于，所述患者端包括患者端控制器和与所述管道相连的输入管，所述输入管上设有控制开关和患者端流量控制器且所述输入管的末端设有对接头，所述控制开关和患者端流量控制器都与所述患者端控制器相连，所述自动仪包括储液罐、自动仪控制器、输送泵和自动仪端流量控制器，所述储液罐通过所述输送泵和自动仪端流量控制器与所述管道相连且所述输送泵和自动仪端流量控制器都与所述自动仪控制器相连。An automatic hydration therapy system used after radionuclide therapy, comprising a patient end located at the head of a bed in a radiation protection ward and an automatic instrument located in the radiation protection ward, wherein the patient end and the automatic instrument are connected via a pipeline, and characterized in that the patient end comprises a patient end controller and an input tube connected to the pipeline, the input tube is provided with a control switch and a patient end flow controller, and the end of the input tube is provided with a docking joint, the control switch and the patient end flow controller are both connected to the patient end controller, the automatic instrument comprises a liquid storage tank, an automatic instrument controller, a delivery pump and an automatic instrument end flow controller, the liquid storage tank is connected to the pipeline via the delivery pump and the automatic instrument end flow controller, and the delivery pump and the automatic instrument end flow controller are both connected to the automatic instrument controller.
优选地，所述核素治疗后使用的自动水化治疗系统进一步包括手持终端，所述患者端还包括与所述患者端控制器相连的患者端无线通信模块，所述患者端通过所述患者端无线通信模块与所述手持终端无线通信。Preferably, the automatic hydration therapy system used after the radionuclide therapy further includes a handheld terminal, and the patient end also includes a patient end wireless communication module connected to the patient end controller, and the patient end communicates wirelessly with the handheld terminal through the patient end wireless communication module.
优选地，所述自动仪还包括与所述自动仪控制器相连的自动仪端无线通信模块，所述自动仪通过所述自动仪端无线通信模块与所述手持终端无线通信。Preferably, the automatic instrument further comprises an automatic instrument end wireless communication module connected to the automatic instrument controller, and the automatic instrument communicates wirelessly with the handheld terminal via the automatic instrument end wireless communication module.
优选地，所述患者端还包括位于所述对接头中的对接传感器，所述对接传感器用于检测所述对接头是否与患者预留的注射针头实现对接且所述对接传感器也与所述患者端控制器相连。Preferably, the patient end further comprises a docking sensor located in the docking head, the docking sensor is used to detect whether the docking head is docked with the injection needle reserved by the patient and the docking sensor is also connected to the patient end controller.
优选地，所述患者端还包括与所述患者端控制器相连的患者端报警器。Preferably, the patient end also includes a patient end alarm connected to the patient end controller.
优选地，所述自动仪还包括位于所述储液罐内的治疗液体传感器，所述治疗液体传感器用于检测所述储液罐内的治疗液体的深度且所述治疗液体传感器也与所述自动仪控制器相连。Preferably, the automatic instrument further comprises a treatment fluid sensor located in the fluid storage tank, the treatment fluid sensor is used to detect the depth of the treatment fluid in the fluid storage tank and the treatment fluid sensor is also connected to the automatic instrument controller.
优选地，所述自动仪还包括与所述自动仪控制器相连的自动仪端报警器。Preferably, the automatic instrument further comprises an automatic instrument end alarm connected to the automatic instrument controller.
与现有技术相比，本发明的核素治疗后使用的自动水化治疗系统具有如下有益技术效果中的一者或多者：Compared with the prior art, the automatic hydration therapy system used after radionuclide therapy of the present invention has one or more of the following beneficial technical effects:
1、其能够自动实现核素治疗后患者的水化治疗，不需要医护人员亲自去进行注射，一方面降低了医护人员的工作强度，另一方面降低了医护人员受到辐射的可能性，再一方面有助于及时对患者进行水化治疗，能够减少患者的辐射损伤和提高患者的核素治疗效果。1. It can automatically achieve hydration therapy for patients after radionuclide therapy, without the need for medical staff to personally perform injections. On the one hand, it reduces the workload of medical staff, on the other hand, it reduces the possibility of medical staff being exposed to radiation, and on the other hand, it helps to provide timely hydration therapy for patients, which can reduce radiation damage to patients and improve the effect of radionuclide therapy for patients.
2、其能够根据患者的情况自动控制患者的治疗液体的注入量，从而能够提高患者的水化治疗效果。2. It can automatically control the amount of therapeutic fluid injected into the patient according to the patient's condition, thereby improving the patient's hydration treatment effect.
3、其能够根据需要水化治疗的患者数量和治疗液体的需求量自动调节治疗液体的供给，从而能够保证水化治疗的效果。3. It can automatically adjust the supply of treatment fluid according to the number of patients requiring hydration therapy and the demand for treatment fluid, thereby ensuring the effect of hydration therapy.
4、其使得医护人员可以远程了解和控制患者的水化治疗，一方面有助于医护人员及时了解患者的水化治疗情况，另一方面能够降低医护人员受到辐射的可能性。4. It allows medical staff to remotely understand and control the patient's hydration treatment. On the one hand, it helps medical staff to understand the patient's hydration treatment status in a timely manner, and on the other hand, it can reduce the possibility of medical staff being exposed to radiation.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1是本发明的核素治疗后使用的水化治疗系统的构成示意图。FIG1 is a schematic diagram showing the structure of a hydration therapy system used after nuclide therapy according to the present invention.
图2是本发明的核素治疗后使用的水化治疗系统的患者端的构成示意图。FIG. 2 is a schematic diagram showing the structure of the patient end of the hydration therapy system used after radionuclide therapy of the present invention.
图3是本发明的核素治疗后使用的水化治疗系统的患者端的控制原理图。FIG3 is a control schematic diagram of the patient end of the hydration therapy system used after radionuclide therapy of the present invention.
图4是本发明的核素治疗后使用的水化治疗系统的自动仪的构成示意图。FIG. 4 is a schematic diagram showing the structure of an automatic instrument of the hydration therapy system used after nuclide therapy of the present invention.
图5是本发明的核素治疗后使用的水化治疗系统的自动仪的控制原理图。FIG. 5 is a control schematic diagram of an automatic instrument of a hydration therapy system used after radionuclide therapy according to the present invention.
具体实施方式Detailed ways
下面结合附图和实施例对本发明进一步说明，实施例的内容不作为对本发明的保护范围的限制。The present invention is further described below in conjunction with the accompanying drawings and embodiments, and the contents of the embodiments are not intended to limit the protection scope of the present invention.
本发明涉及一种核素治疗后使用的自动水化治疗系统，其用于在为患者行核素131碘化钠内照射治疗后，给予患者自动水化治疗，从而加快患者体内放射性核素物质的排泄，缓解放射线为患者带来的辐射损伤。The present invention relates to an automatic hydration therapy system used after radionuclide therapy, which is used to give automatic hydration therapy to patients after radionuclide131 sodium iodide internal irradiation therapy for patients, thereby accelerating the excretion of radioactive nuclide substances in the patient's body and alleviating the radiation damage caused by radiation to the patient.
图1示出了本发明的核素治疗后使用的水化治疗系统的构成示意图。如图1所示，本发明的核素治疗后使用的自动水化治疗系统包括位于辐射防护病房A的病床B的床头的患者端1和位于辐射防护病区内的自动仪2。所述患者端1和自动仪2通过管道3相连。FIG1 shows a schematic diagram of the composition of the hydration therapy system used after the nuclide therapy of the present invention. As shown in FIG1 , the automatic hydration therapy system used after the nuclide therapy of the present invention comprises a patient end 1 located at the head of the bed B of the radiation protection ward A and an automatic instrument 2 located in the radiation protection ward. The patient end 1 and the automatic instrument 2 are connected by a pipe 3.
所述自动仪2用于提供水化治疗所需要的治疗液体并使得治疗液体能够通过所述管道3输送到所述患者端1处。所述患者端1用于与患者预埋的静脉通道相连，以将治疗液体注射到患者体内，从而实现对患者的水化治疗。The automatic device 2 is used to provide the therapeutic liquid required for hydration therapy and enables the therapeutic liquid to be delivered to the patient end 1 through the pipeline 3. The patient end 1 is used to be connected to the patient's pre-buried venous channel to inject the therapeutic liquid into the patient's body, thereby achieving hydration therapy for the patient.
图2示出了本发明的核素治疗后使用的水化治疗系统的患者端1的构成示意图。如图2所示，所述患者端1包括患者端控制器1.1和与所述管道3相连的输入管1.2。Fig. 2 shows a schematic diagram of the patient end 1 of the hydration therapy system used after radionuclide therapy of the present invention. As shown in Fig. 2 , the patient end 1 includes a patient end controller 1.1 and an input tube 1.2 connected to the pipeline 3.
所述输入管1.2上设有控制开关1.3和患者端流量控制器1.4且所述输入管1.2的末端设有对接头1.5。所述控制开关1.3能够控制是否向患者体内注射治疗液体。所述患者端流量控制器1.4能够计量向患者注射的治疗液体的流量。所述对接头1.5用于与患者预埋的注射针头对接，从而便于将来自所述自动仪2的治疗液体注射到患者体内，以实现对患者的水化治疗。The input tube 1.2 is provided with a control switch 1.3 and a patient-end flow controller 1.4, and a docking joint 1.5 is provided at the end of the input tube 1.2. The control switch 1.3 can control whether to inject the therapeutic liquid into the patient's body. The patient-end flow controller 1.4 can measure the flow rate of the therapeutic liquid injected into the patient. The docking joint 1.5 is used to dock with the injection needle pre-buried in the patient, so as to facilitate the injection of the therapeutic liquid from the automatic instrument 2 into the patient's body to achieve hydration therapy for the patient.
如图3所示，所述控制开关1.3和患者端流量控制器1.4都与所述患者端控制器1.1相连。As shown in FIG. 3 , the control switch 1.3 and the patient-side flow controller 1.4 are both connected to the patient-side controller 1.1.
由此，所述患者端控制器1.1能够控制所述控制开关1.3是否打开，从而能够控制是否向患者体内注射治疗液体。并且，所述患者端流量控制器1.4一方面能够实现对患者注射的治疗液体的计量，另一方面能够实现对患者注射的治疗液体的注射速度和量的控制，并将其计量和控制结果发送给所述患者端控制器1.1。Thus, the patient-side controller 1.1 can control whether the control switch 1.3 is turned on, thereby controlling whether the therapeutic liquid is injected into the patient. In addition, the patient-side flow controller 1.4 can measure the therapeutic liquid injected into the patient on the one hand, and control the injection speed and amount of the therapeutic liquid injected into the patient on the other hand, and send its measurement and control results to the patient-side controller 1.1.
图4示出了本发明的核素治疗后使用的水化治疗系统的自动仪的构成示意图。如图4所示，所述自动仪2包括储液罐2.1、自动仪控制器2.3、输送泵2.5和自动仪端流量控制器2.6。Fig. 4 shows a schematic diagram of the structure of the automatic instrument of the hydration therapy system used after radionuclide therapy of the present invention. As shown in Fig. 4, the automatic instrument 2 includes a liquid storage tank 2.1, an automatic instrument controller 2.3, a delivery pump 2.5 and an automatic instrument end flow controller 2.6.
所述储液罐2.1用于储存水化治疗用的治疗液体。所述储液罐2.1通过所述输送泵2.5和自动仪端流量控制器2.6与所述管道3相连。The liquid storage tank 2.1 is used to store the therapeutic liquid for hydration therapy and is connected to the pipeline 3 through the delivery pump 2.5 and the automatic instrument end flow controller 2.6.
这样，所述输送泵2.5能够将所述储液罐2.1内的治疗液体抽吸出来并通过所述管道3向所述患者端1输送。所述自动仪端流量控制器2.6一方面能够实现从所述储液罐1内抽吸出的治疗液体的计量，另一方面能够实现对从所述储液罐1内抽吸的治疗液体的抽吸速度和量的控制。In this way, the delivery pump 2.5 can suck out the treatment liquid in the liquid storage tank 2.1 and deliver it to the patient end 1 through the pipeline 3. The automatic instrument end flow controller 2.6 can achieve the metering of the treatment liquid sucked out from the liquid storage tank 1 on the one hand, and can achieve the control of the suction speed and amount of the treatment liquid sucked from the liquid storage tank 1 on the other hand.
如图5所示，所述输送泵2.5和自动仪端流量控制器2.6都与所述自动仪控制器2.3相连。As shown in FIG. 5 , the delivery pump 2.5 and the flow controller 2.6 at the automatic instrument end are both connected to the automatic instrument controller 2.3.
由此，所述自动仪控制器2.3能够控制所述输送泵2.5是否启动，以控制是否向所述患者端1输送治疗液体。并且，所述自动仪端流量控制器2.6除了实现计量和控制之外，还能够将其计量和控制结果发送给所述自动仪控制器2.3。Thus, the automatic instrument controller 2.3 can control whether the delivery pump 2.5 is started to control whether the treatment liquid is delivered to the patient end 1. In addition, the automatic instrument end flow controller 2.6 can send its measurement and control results to the automatic instrument controller 2.3 in addition to achieving measurement and control.
继续参考图1，在本发明中，所述核素治疗后使用的自动水化治疗系统进一步包括手持终端4。并且，如图3所示，所述患者端1还包括与所述患者端控制器1.1相连的患者端无线通信模块。所述患者端1通过所述患者端无线通信模块与所述手持终端4无线通信。Continuing to refer to FIG. 1 , in the present invention, the automatic hydration therapy system used after the radionuclide therapy further includes a handheld terminal 4. Moreover, as shown in FIG. 3 , the patient end 1 also includes a patient end wireless communication module connected to the patient end controller 1.1. The patient end 1 communicates wirelessly with the handheld terminal 4 via the patient end wireless communication module.
这样，一方面可以将患者的治疗液体的注射情况及时发送到所述手持终端4，以便于医护人员及时了解患者的水化治疗情况；另一方面，医护人员可以通过所述手持终端4将控制指令，例如，患者需要注入的治疗液体的量发送到所述患者端1，从而有助于实现医护人员对患者的水化治疗的远程控制。In this way, on the one hand, the injection status of the patient's therapeutic fluid can be sent to the handheld terminal 4 in a timely manner, so that medical staff can understand the patient's hydration treatment status in a timely manner; on the other hand, medical staff can send control instructions, such as the amount of therapeutic fluid that the patient needs to inject, to the patient end 1 through the handheld terminal 4, thereby helping medical staff to remotely control the patient's hydration treatment.
此外，如图5所示，所述自动仪2还包括与所述自动仪控制器2.3相连的自动仪端无线通信模块。所述自动仪2通过所述自动仪端无线通信模块与所述手持终端4无线通信。In addition, as shown in Fig. 5, the robot 2 further includes a robot-side wireless communication module connected to the robot controller 2.3. The robot 2 communicates with the handheld terminal 4 wirelessly via the robot-side wireless communication module.
这样，一方面可以将治疗液体的抽吸情况及时发送到所述手持终端4，以便于医护人员及时了解治疗液体的使用量；另一方面，医护人员可以通过所述手持终端4将控制指令，例如，需要从所述储液罐1内抽吸的治疗液体的量发送到所述自动仪2，从而有助于实现医护人员对所述自动仪2的远程控制。In this way, on the one hand, the suction status of the therapeutic fluid can be sent to the handheld terminal 4 in a timely manner, so that medical staff can timely understand the usage of the therapeutic fluid; on the other hand, medical staff can use the handheld terminal 4 to send control instructions, for example, the amount of therapeutic fluid that needs to be sucked from the fluid storage tank 1 to the automatic instrument 2, thereby helping medical staff to remotely control the automatic instrument 2.
在本发明中，优选地，所述患者端1还包括位于所述对接头1.5中的对接传感器。所述对接传感器用于检测所述对接头1.5是否与患者预留的注射针头实现对接。并且，继续参考图3，所述对接传感器也与所述患者端控制器1.1相连。In the present invention, preferably, the patient end 1 further comprises a docking sensor located in the docking head 1.5. The docking sensor is used to detect whether the docking head 1.5 is docked with the injection needle reserved by the patient. And, referring to FIG. 3 , the docking sensor is also connected to the patient end controller 1.1.
这样，所述对接传感器可以检测到所述对接头1.5是否与患者预留的注射针头实现对接，并将检测结果发送到所述患者端控制器1.1。由此，所述患者端控制器1.1可以在所述对接头1.5与患者预留的注射针头实现对接的情况下才会打开所述控制开关1.3，否则将不打开所述控制开关1.3，从而能够确保治疗液体都进入患者体内。因此，其能够进一步实现治疗的精确控制。In this way, the docking sensor can detect whether the docking connector 1.5 is docked with the injection needle reserved by the patient, and send the detection result to the patient-side controller 1.1. Therefore, the patient-side controller 1.1 can turn on the control switch 1.3 only when the docking connector 1.5 is docked with the injection needle reserved by the patient, otherwise the control switch 1.3 will not be turned on, thereby ensuring that the treatment liquid enters the patient's body. Therefore, it can further achieve precise control of treatment.
更优选地，如图2和3所示，所述患者端1还包括与所述患者端控制器1.1相连的患者端报警器1.6。More preferably, as shown in FIGS. 2 and 3 , the patient end 1 further comprises a patient end alarm 1 .6 connected to the patient end controller 1 .1 .
由此，在患者的治疗液体的注入量达到设定量的时候，如果所述控制开关1.3出现失灵现象而无法关闭的情况，所述患者端报警器1.6可以进行报警，从而提供患者手动关闭所述控制开关1.3。或者，在治疗液体的注入量还没达到设定量时，由于某种原因不能再注射治疗液体了，此时，所述患者端报警器1.6也可以进行报警，提醒患者缺少治疗液体。并且，报警信息可以通过无线通信的方式传输到所述手持终端4，以提醒医护人员注意发生的报警，有助于医护人员及时进行处理。Thus, when the amount of treatment fluid injected into the patient reaches the set amount, if the control switch 1.3 fails and cannot be closed, the patient-side alarm 1.6 can sound an alarm, thereby providing the patient with the opportunity to manually close the control switch 1.3. Alternatively, when the amount of treatment fluid injected has not yet reached the set amount, the treatment fluid cannot be injected for some reason. At this time, the patient-side alarm 1.6 can also sound an alarm to remind the patient that the treatment fluid is lacking. In addition, the alarm information can be transmitted to the handheld terminal 4 by wireless communication to remind medical staff to pay attention to the alarm, which helps medical staff to handle it in a timely manner.
同时，在本发明中，优选地，如图4所示，所述自动仪2还包括位于所述储液罐2.1内的治疗液体传感器2.2。所述治疗液体传感器2.2用于检测所述储液罐2.1内的治疗液体的深度。Meanwhile, in the present invention, preferably, as shown in Fig. 4, the automatic device 2 further comprises a treatment liquid sensor 2.2 located in the liquid storage tank 2.1. The treatment liquid sensor 2.2 is used to detect the depth of the treatment liquid in the liquid storage tank 2.1.
如图5所示，所述治疗液体传感器2.2也与所述自动仪控制器2.3相连。由此，所述治疗液体传感器2.2可以将其检测结果发送到所述自动仪控制器2.3。As shown in Fig. 5, the treatment fluid sensor 2.2 is also connected to the automatic instrument controller 2.3, so that the treatment fluid sensor 2.2 can send its detection result to the automatic instrument controller 2.3.
由此，在所述治疗液体传感器2检测到所述储液罐2.1内的治疗液体的量较少时，可以将相关信息发送到所述手持终端4，提醒医护人员及时往所述储液罐2.1内添加治疗液体。Therefore, when the treatment fluid sensor 2 detects that the amount of treatment fluid in the fluid storage tank 2.1 is small, relevant information can be sent to the handheld terminal 4 to remind medical staff to add treatment fluid to the fluid storage tank 2.1 in time.
更优选地，如图4和5所示，所述自动仪2还包括与所述自动仪控制器2.3相连的自动仪端报警器2.4。More preferably, as shown in FIGS. 4 and 5 , the robot 2 further comprises a robot-end alarm 2.4 connected to the robot controller 2.3.
所述自动仪端报警器2.4可以在某些情况下自动报警并通过无线通信的方式把报警信息传输到所述手持终端4，以提醒医护人员注意。例如，当所述治疗液体传感器2.2检测到所述储液罐2.1内的治疗液体低于一定程度时，所述自动仪端报警器2.4进行报警，以提供医护人员往所述储液罐2.1内添加治疗液体。The automatic instrument-side alarm 2.4 can automatically alarm in certain situations and transmit the alarm information to the handheld terminal 4 by wireless communication to alert the medical staff. For example, when the treatment liquid sensor 2.2 detects that the treatment liquid in the liquid storage tank 2.1 is lower than a certain level, the automatic instrument-side alarm 2.4 will alarm to prompt the medical staff to add treatment liquid to the liquid storage tank 2.1.
在使用本发明的核素治疗后使用的自动水化治疗系统时，需要将所述患者端1安装在辐射防护病房A的病床B的床头处。同时，在病人行核素131碘化钠内照射治疗后，医护人员为患者建立静脉通道，也就是，将注射针头预埋在患者的静脉中，以便于对患者进行注射治疗。同时，医护人员会将治疗液体注入到所述储液罐2.1内。When using the automatic hydration therapy system used after radionuclide therapy of the present invention, the patient end 1 needs to be installed at the head of the bed B in the radiation protection ward A. At the same time, after the patient undergoes radionuclide131 sodium iodide internal irradiation therapy, the medical staff establishes a venous channel for the patient, that is, pre-buries the injection needle in the patient's vein, so as to facilitate injection therapy for the patient. At the same time, the medical staff will inject the treatment liquid into the liquid storage tank 2.1.
在需要进行水化治疗时，使得所述对接头1.5与患者预埋的注射针头对接(这种对接可以是医护人员进行，也可以患者在接收到医护人员的指令后自主进行)。并且，医护人员可以根据患者的情况通过所述手持终端4设定好患者需要注入的治疗液体的量，然后发送给所述患者端控制器1.1和自动仪控制器2.3。其中，发送给所述患者端控制器1.1的是该患者需要注入的治疗液体的量。发送给所述自动仪控制器2.3的是该辐射防护病区内同时需要进行水化治疗的所有患者所需要注入的治疗液体的量。When hydration therapy is required, the docking connector 1.5 is docked with the pre-buried injection needle of the patient (this docking can be performed by medical staff or by the patient independently after receiving instructions from the medical staff). In addition, the medical staff can set the amount of therapeutic liquid that the patient needs to be injected through the handheld terminal 4 according to the patient's condition, and then send it to the patient-side controller 1.1 and the automatic instrument controller 2.3. Among them, the amount of therapeutic liquid that needs to be injected into the patient is sent to the patient-side controller 1.1. The amount of therapeutic liquid that needs to be injected into the patient is sent to the automatic instrument controller 2.3. The amount of therapeutic liquid that needs to be injected into all patients who need hydration therapy at the same time in the radiation protection ward is sent to the automatic instrument controller 2.3.
之后，所述自动仪控制器2.3控制所述输送泵2.5打开，以将所述储液罐2.1内的治疗液体向外输送。同时，所述自动仪端流量控制器2.6开始计算向外输送的治疗液体的流量。Afterwards, the automatic instrument controller 2.3 controls the delivery pump 2.5 to turn on to deliver the treatment liquid in the liquid storage tank 2.1 to the outside. At the same time, the automatic instrument end flow controller 2.6 starts to calculate the flow rate of the treatment liquid delivered to the outside.
与此同时，所述患者端控制器1.1控制所述控制开关1.3打开以向患者注射治疗液体。同时，所述患者端流量控制器1.4开始计算向患者注射的治疗液体的流量。At the same time, the patient-side controller 1.1 controls the control switch 1.3 to open so as to inject the therapeutic liquid into the patient. At the same time, the patient-side flow controller 1.4 starts to calculate the flow of the therapeutic liquid injected into the patient.
当某一个患者的治疗液体的注射量达到设定量时，所述患者端控制器1.1会自动控制所述控制开关1.3关闭，以不在向该患者注射治疗液体。When the injection volume of the treatment fluid for a certain patient reaches the set volume, the patient-side controller 1.1 will automatically control the control switch 1.3 to close so as not to inject the treatment fluid into the patient.
当所有患者都治疗完毕之后，所述自动仪控制器2.3会控制所述输入泵2.5关闭，以不再提供治疗液体。When all patients have been treated, the automatic device controller 2.3 will control the input pump 2.5 to turn off so as to stop providing treatment fluid.
并且，在此期间，所述患者端控制器1.1和自动仪控制器2.3都会通过无线通信的方式与所述手持终端4进行无线通信，以将患者的治疗液体注入情况和治疗液体的提供情况及时反馈给所述手持终端4，从而便于医护人员了解患者的治疗情况。并且，所述手持终端4也可以通过无线通信的方式向所述患者端控制器1.1和自动仪控制器2.3发送指令，以便于调节患者的治疗液体的注入量。Moreover, during this period, the patient-side controller 1.1 and the automatic instrument controller 2.3 will communicate with the handheld terminal 4 by wireless communication, so as to timely feedback the patient's treatment fluid injection and treatment fluid supply to the handheld terminal 4, so as to facilitate medical staff to understand the patient's treatment status. Moreover, the handheld terminal 4 can also send instructions to the patient-side controller 1.1 and the automatic instrument controller 2.3 by wireless communication, so as to adjust the injection amount of the patient's treatment fluid.
此外，在水化治疗期间，如果出现意外情况，所述患者端报警器1.6和自动仪端报警器2.4都会进行报警，并会将报警信息传输到所述手持终端4，以便于医护人员及时了解相关情况并及时进行处理。In addition, during the hydration treatment, if an unexpected situation occurs, the patient-side alarm 1.6 and the automatic instrument-side alarm 2.4 will both sound an alarm, and transmit the alarm information to the handheld terminal 4, so that medical staff can promptly understand the relevant situation and handle it in time.
本发明的核素治疗后使用的自动水化治疗系统能够自动实现核素治疗后患者的水化治疗，不需要医护人员亲自去进行注射，一方面降低了医护人员的工作强度，另一方面减少了医护人员受到辐射的可能性，再一方面有助于及时对患者进行水化治疗，能够减少患者的辐射损伤和提高患者的核素治疗效果。The automatic hydration therapy system used after radionuclide therapy of the present invention can automatically achieve hydration therapy for patients after radionuclide therapy, without the need for medical staff to personally perform injections. On the one hand, it reduces the workload of medical staff, on the other hand, it reduces the possibility of medical staff being exposed to radiation, and on the other hand, it helps to perform hydration therapy on patients in a timely manner, which can reduce radiation damage to patients and improve the radionuclide therapy effect of patients.
本发明的上述实施例仅仅是为清楚地说明本发明所作的举例，而并非是对本发明的实施方式的限定。对于所属领域的普通技术人员来说，在上述说明的基础上还可以做出其它不同形式的变化或变动。这里无法对所有的实施方式予以穷举。凡是属于本发明的技术方案所引伸出的显而易见的变化或变动仍处于本发明的保护范围之列。The above embodiments of the present invention are merely examples for clearly illustrating the present invention, and are not intended to limit the embodiments of the present invention. For those skilled in the art, other different forms of changes or modifications can be made based on the above description. It is impossible to list all the embodiments here. Any obvious changes or modifications derived from the technical solution of the present invention are still within the scope of protection of the present invention.
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111466443.6ACN114432530B (en) | 2021-12-03 | 2021-12-03 | An automatic hydration therapy system used after radionuclide therapy |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111466443.6ACN114432530B (en) | 2021-12-03 | 2021-12-03 | An automatic hydration therapy system used after radionuclide therapy |
| Publication Number | Publication Date |
|---|---|
| CN114432530A CN114432530A (en) | 2022-05-06 |
| CN114432530Btrue CN114432530B (en) | 2024-04-26 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111466443.6AActiveCN114432530B (en) | 2021-12-03 | 2021-12-03 | An automatic hydration therapy system used after radionuclide therapy |
| Country | Link |
|---|---|
| CN (1) | CN114432530B (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5472403A (en)* | 1993-05-11 | 1995-12-05 | The Regents Of The University Of California | Device for automatic injection of radionuclide |
| CN212699898U (en)* | 2020-02-21 | 2021-03-16 | 中国人民解放军陆军军医大学第一附属医院 | Remote drug delivery system |
| CN112827060A (en)* | 2021-01-05 | 2021-05-25 | 胡亮 | Method and layout structure for remotely injecting radiopharmaceuticals |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7566320B2 (en)* | 2001-02-14 | 2009-07-28 | Acist Medical Systems, Inc. | Fluid injector system |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5472403A (en)* | 1993-05-11 | 1995-12-05 | The Regents Of The University Of California | Device for automatic injection of radionuclide |
| CN212699898U (en)* | 2020-02-21 | 2021-03-16 | 中国人民解放军陆军军医大学第一附属医院 | Remote drug delivery system |
| CN112827060A (en)* | 2021-01-05 | 2021-05-25 | 胡亮 | Method and layout structure for remotely injecting radiopharmaceuticals |
| Publication number | Publication date |
|---|---|
| CN114432530A (en) | 2022-05-06 |
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0611034A2 (en) | contrast fluid sending system | |
| CN114432530B (en) | An automatic hydration therapy system used after radionuclide therapy | |
| CN204017120U (en) | A kind of supplementary priming device | |
| CN105073157B (en) | Valveless drug infusion system | |
| CN103691030A (en) | Automatic filled injection pump system | |
| CN201710813U (en) | Infusion device with capabilities of automatic medicine delivery and radiation shielding | |
| CN2875449Y (en) | Gallstone dissolving instrument | |
| CN104998335A (en) | PICC thrombolysis apparatus | |
| CN206275880U (en) | A kind of full-automatic perfusion system | |
| CN222854363U (en) | Automatic drug delivery device | |
| WO2023036338A1 (en) | High-pressure contrast injector and accessories | |
| CN102406969A (en) | Double-row double-layer filling pipeline device | |
| CN210844668U (en) | A drug stress myocardial perfusion ultrasound imaging inspection device | |
| CN219579555U (en) | Enema device | |
| CN223208815U (en) | Radiopharmaceutical injection device | |
| CN201939816U (en) | Automatic warning device for infusion tube | |
| CN204815290U (en) | PICC dissolves bolt apparatus | |
| CN219646496U (en) | A circulation perfusion device for injection treatment of vascular malformations | |
| CN204563089U (en) | That rinses for venous chambers in a kind of No heparinization HD therapy process injects system | |
| CN206026781U (en) | Double plug safety transfusion system | |
| CN221637052U (en) | Catheter for intravascular interventional therapy | |
| CN216169190U (en) | Transfusion system capable of directly administering and connecting pump tube | |
| CN203525127U (en) | Contrast agent leading-in device for retrograde urinary tract contrast examination | |
| CN209967400U (en) | Disposable Safety Chemotherapy Infuser | |
| CN216676589U (en) | A liquid medicine supply pipeline device with one-way valve |
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |